MALVERN, Pa., March 11, 2025 /PRNewswire/ — Endo, Inc. (“Endo” or the “Company”) (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals business, primarily operated through Canada-based specialty […]
Tag: Endo
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
MALVERN, Pa., March 10, 2025 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) (“Endo” or the “Company”) announced today that it has rescheduled the release of its fourth quarter and full year 2024 financial results to March […]
Endo Launches “Steve’s Journey,” the First Branded Dupuytren’s Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Campaign builds on the momentum of Endo’s disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal experience with the condition and […]
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
20,000-square-foot site increases Endo’s sterile injectable production capacity This marks the site’s first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions business MALVERN, Pa., Dec. 9, 2024 /PRNewswire/ — Endo, Inc. […]
John Elway Teams Up with Endo to Share Update on Dupuytren’s Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)
MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ — Endo, Inc. (“Endo”) (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren’s contracture patient journey, including his treatment with XIAFLEX® (collagenase clostridium histolyticum) […]
